Schroder Investment Management Group’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-153,769
| Closed | -$1M | – | 1252 |
|
|
2024
Q2 | $1M | Hold |
153,769
| – | – | ﹤0.01% | 1028 |
|
|
2024
Q1 | $1.28M | Buy |
+153,769
| New | +$1.28M | ﹤0.01% | 986 |
|
|
2023
Q4 | – | Sell |
-205,420
| Closed | -$1.73M | – | 1262 |
|
|
2023
Q3 | $1.73M | Sell |
205,420
-15,062
| -7% | -$127K | ﹤0.01% | 938 |
|
|
2023
Q2 | $2.77M | Sell |
220,482
-47,626
| -18% | -$598K | ﹤0.01% | 888 |
|
|
2023
Q1 | $4.42M | Buy |
268,108
+29,866
| +13% | +$492K | 0.01% | 811 |
|
|
2022
Q4 | $3.56M | Buy |
238,242
+90,606
| +61% | +$1.35M | 0.01% | 841 |
|
|
2022
Q3 | $3.3M | Sell |
147,636
-23,500
| -14% | -$526K | 0.01% | 855 |
|
|
2022
Q2 | $2.87M | Buy |
171,136
+86,491
| +102% | +$1.45M | ﹤0.01% | 908 |
|
|
2022
Q1 | $2.6M | Buy |
+84,645
| New | +$2.6M | ﹤0.01% | 966 |
|